AOD9604

AOD-9604 selectively targets the region associated with fat metabolism while leaving IGF-1 and insulin signalling pathways unaffected. This selectivity makes it useful in research settings where the goal is to examine lipolysis without the confounding influences of growth promotion, glucose regulation changes, or broader anabolic effects.

Studies suggest AOD-9604 may act through several pathways:

• Interacts with beta-3-adrenergic receptors on white adipose tissue to initiate metabolic signalling.
• Stimulates the lipolytic breakdown of stored triglycerides into free fatty acids and glycerol for energy utilization.
• May reduce the formation of new fat from excess carbohydrates.
• Promotes cartilage matrix maintenance and repair, potentially via localized growth factor pathways independent of systemic fat metabolism.

Common research areas:

• Obesity and metabolic regulation studies
• Fat oxidation and adrenergic signalling pathways
• Cartilage repair and joint degradation models
• Metabolic syndrome and lipid profile research
• Comparative studies of growth hormone fragments and IGF-1–independent mechanisms